Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
Capricor Therapeutics, Inc. (CAPR)
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
capricor.com/investors
Company Research
Source: GlobeNewswire
SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is set to join the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets today, July 1, 2024. “We are thrilled to be joining the Russell 2000® Index, a testament to our Company’s progress across our pipeline marked by significant advancements in our lead program for the treatment of Duchenne muscular dystrophy,” said Linda Marbán, Ph.D., Capricor’s chief executive officer. “This milestone reflects Capricor’s commitment to developing groundbreaking therapies that make a meaningful impact on patients’ lives. With the addition to these indexes, we look forward to increasing our exposure to the investment community.” The annual Russell indexes reconstitution captures the 4,000 largest U.S. s
Show less
Read more
Impact Snapshot
Event Time:
CAPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAPR alerts
High impacting Capricor Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CAPR
News
- Capricor Therapeutics to Present at Upcoming Investor and Scientific ConferencesGlobeNewswire
- DMD clinical studies evolve with emphasis on building designs around relevant endpoints [Yahoo! Finance]Yahoo! Finance
- Things Look Grim For Capricor Therapeutics, Inc. (NASDAQ:CAPR) After Today's Downgrade [Yahoo! Finance]Yahoo! Finance
- Capricor Therapeutics, Inc. (CAPR) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
CAPR
Earnings
- 8/7/24 - Miss
CAPR
Analyst Actions
- 7/2/24 - HC Wainwright
CAPR
Sec Filings
- 8/23/24 - Form SC
- 8/23/24 - Form 3
- 8/9/24 - Form 4
- CAPR's page on the SEC website